Kyle Malady Dexcom Inc (DXCM) insider trading activity
Kyle Malady is Director of DEXCOM INC. Currently has a direct ownership of 18,142 shares of DXCM, which is worth approximately $1.24 Million. The most recent transaction as insider was on May 22, 2024, when has been sold 2,613 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
18.1K
0%
3M change
16.83%
12M change
Total Value Held
$1.24 Million
Kyle Malady Transaction History
Also insider at
KM
Kyle Malady
Director
New York, NY